| Literature DB >> 34943959 |
Maryke Wijma1, Carolina Gimiliani Lembke1, Augusto Lima Diniz1, Luciane Santini1, Leonardo Zambotti-Villela1, Pio Colepicolo1, Monalisa Sampaio Carneiro2, Glaucia Mendes Souza1.
Abstract
To reduce the potentially irreversible environmental impacts caused by fossil fuels, the use of renewable energy sources must be increased on a global scale. One promising source of biomass and bioenergy is sugarcane. The study of this crop's development in different planting seasons can aid in successfully cultivating it in global climate change scenarios. The sugarcane variety SP80-3280 was field grown under two planting seasons with different climatic conditions. A systems biology approach was taken to study the changes on physiological, morphological, agrotechnological, transcriptomics, and metabolomics levels in the leaf +1, and immature, intermediate and mature internodes. Most of the variation found within the transcriptomics and metabolomics profiles is attributed to the differences among the distinct tissues. However, the integration of both transcriptomics and metabolomics data highlighted three main metabolic categories as the principal sources of variation across tissues: amino acid metabolism, biosynthesis of secondary metabolites, and xenobiotics biodegradation and metabolism. Differences in ripening and metabolite levels mainly in leaves and mature internodes may reflect the impact of contrasting environmental conditions on sugarcane development. In general, the same metabolites are found in mature internodes from both "one-year" and "one-and-a-half-year sugarcane", however, some metabolites (i.e., phenylpropanoids with economic value) and natural antisense transcript expression are only detected in the leaves of "one-year" sugarcane.Entities:
Keywords: HPLC-MS; SP80-3280; antisense expression; metabolomics; multi-omics integration; oligoarray; secondary metabolism; sugarcane; systems biology; transcriptomics
Mesh:
Substances:
Year: 2021 PMID: 34943959 PMCID: PMC8700069 DOI: 10.3390/cells10123451
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1Experimental design and guide to datasets. (A) The sugarcane variety SP80-3280 was field grown under two planting seasons (Fall and Spring) with different climatic conditions and data and sample collection were done after 4 (C1), 8 (C2), 11 (C3) and 13 (C4) months after planting (P). (B) Plant material collected for molecular analysis: leaf +1 (L1), immature (I1), intermediate (I5) and mature internodes. A systems biology approach was taken to study the changes on (C) physiological, morphological, agrotechnological, (D) transcriptomics, and metabolomics levels. (E) The MOFA tool was used to point out the main metabolic pathways that were activated and altered throughout development. (F) Finally, comparisons between the results from Field 1 and Field 2 were done in each sugarcane tissue studied.
Figure 2Precipitation and temperature during the initial months after sugarcane planting affect initial sugarcane elongation and stalk height, width, and soluble solids content at the stage of ripening. (A) Precipitation and temperature measures of fields 1 (F1) and 2 (F2). (B) Stalk-height, (C) stalk width, (D) number of internodes, and (E) soluble solids content in F1 and F2 in 4 (C1), 8 (C2), 11 (C3), and 13 (C4)-month-old plants. Letters and * are from the split2.crd results. Means with the same letter are not significantly different and means with different letters are significantly different between collection points. * shows differences between F1 and F2. Error bars show the standard error of the mean.
Figure 3Multidimensional scaling (MDS) analyses of the transcriptomics data demonstrated that most of the variation within transcriptomics profiles is attributed to the differences between the distinct anatomical tissues. (A) Dim1 vs. Dim2; (B) Dim1 vs. Dim3. (C) Heatmap constructed using the top 500 most variable genes responsible for the variations in the different tissues. L1, I1, I5, and I9 refer to leaf +1 and immature, intermediate, and mature internodes. F1 and F2 refer to the plants that were planted in April 2012 and October 2012, respectively. C1, C2, C3, and C4 refer to sampling points at 4, 8, 11, and 13 months after planting.
Figure 4The Venn diagram shows that Leaf +1 presented a higher number of identified metabolites in the metabolite profiles generated via HPLC-MS of each tissue collected throughout sugarcane SP80-3280 development in both fields.
Figure 5Discriminant models of the metabolomics data demonstrated that most of the variation within metabolomics profiles is attributed to the differences between the distinct anatomical tissues. (A) PCA and (B) PLS−DA models generated from dry weight (DW) normalized and log10 transformed metabolomics data, combining all tissues (L1, I1, I5, and I9), sampling points (C1, C2, C3, and C4) and experimental fields (F1 and F2) (component 1 Q2 = 0.98761, R2 = 0.9882 and component 2 Q2 = 0.99452, R2 = 0.99516). (C) Heatmap representation of the 79 main metabolites responsible for the separations (VIP scores ≥1.0 from PLS-DA analysis). The list of the 79 metabolites names is available in the Table S16.
An integrative view of the combined output results from MOFA for the leaf +1 (L1), immature (I1), intermediate (I5), and mature internodal (I9) tissues.
| Tissue | Transcriptomics Data Modality | Metabolomics Data Modality | ||
|---|---|---|---|---|
| GO ID | GO Term | KEGG Map ID | KEGG Map Name | |
| L1 | GO:0044281 | small molecule metabolic process | map00940 | Phenylpropanoid biosynthesis |
| GO:0006520 | cellular amino acid metabolic process | map00941 | Flavonoid biosynthesis | |
| GO:0043436 | oxoacid metabolic process | map00360 | Phenylalanine metabolism | |
| GO:0006082 | organic acid metabolic process | map00640 | Cyanoamino acid metabolism | |
| GO:0019752 | carboxylic acid metabolic process | map00966 | Glucosinolate biosynthesis | |
| GO:1901566 | organonitrogen compound biosynthetic process | map00030 | Pentose phosphate pathway | |
| GO:0008652 | cellular amino acid biosynthetic process | map00400 | Phenylalanine, tyrosine and tryptophan metabolism | |
| GO:1901605 | alpha-amino acid metabolic process | map00380 | Tryptophan metabolism | |
| GO:0044283 | small molecule biosynthetic process | map00362 | Benzoate degradation | |
| GO:1901607 | alpha-amino acid biosynthetic process | map00960 | Tropane, piperidine and pyridine alkaloid biosynthesis | |
| GO:0016311 | Dephosphorylation | map00350 | Tyrosine metabolism | |
| GO:0051186 | cofactor metabolic process | map00623 | Toluene degradation | |
| GO:0017144 | drug metabolic process | map00627 | Aminobenzoate degradation | |
| GO:0055086 | nucleobase-containing small molecule metabolism | map00130 | Ubiquinone and other terpenoid-quinone biosynthesis | |
| I1 | GO:0010035 | response to inorganic substance | map00943 | Isoflavonoid biosynthesis |
| GO:0010077 | maintenance of inflorescence meristem identity | map00966 | Glucosinolate biosynthesis | |
| GO:0009414 | response to water deprivation | map00944 | Flavone and flavonol biosynthesis | |
| GO:0006952 | defense response | map00680 | Methane metabolism | |
| GO:0009415 | response to water | map00360 | Phenylalanine metabolism | |
| GO:0005980 | glycogen catabolic process | map00940 | Phenylpropanoid biosynthesis | |
| GO:0046398 | UDP-glucuronate metabolic process | map00998 | Biosynthesis of secondary metabolites-unclassified | |
| GO:0050832 | defense response to fungus | map00130 | Ubiquinone and other terpenoid-quinone biosynthesis | |
| GO:0006950 | response to stress | map00980 | Metabolism of xenobiotics by cytochrome P450 | |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | map00524 | Neomycin, kanamycin and gentamicin biosynthesis | |
| GO:0006457 | protein folding | map00950 | Isoquinoline alkaloid biosynthesis | |
| GO:0061077 | chaperone-mediated protein folding | map00350 | Tyrosine metabolism | |
| GO:0006298 | mismatch repair | map00564 | Glycerophospholipid metabolism | |
| GO:0050896 | response to stimulus | map00965 | Betalain biosynthesis | |
| GO:0032508 | DNA duplex unwinding | map00261 | Monobactam biosynthesis | |
| GO:0051704 | multi-organism process | map00410 | beta-Alanine metabolism | |
| GO:0009620 | response to fungus | map01055 | Biosynthesis of vancomycin group antibiotics | |
| GO:0032392 | DNA geometric change | map00480 | Glutathione metabolism | |
| I5 | GO:0005975 | carbohydrate metabolic process | map00908 | Zeatin biosynthesis |
| GO:0051186 | cofactor metabolic process | map00954 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | |
| GO:0017144 | drug metabolic process | map00564 | Glycerophospholipid metabolism | |
| GO:0042737 | drug catabolic process | map00230 | Purine metabolism | |
| GO:0098754 | Detoxification | map00640 | Propanoate metabolism | |
| GO:0009636 | response to toxic substance | map00770 | Pantothenate and CoA biosynthesis | |
| GO:0045229 | external encapsulating structure organization | map00626 | Naphthalene degradation | |
| GO:0044281 | small molecule metabolic process | map00361 | Chlorocyclohexane and chlorobenzene degradation | |
| GO:0055086 | nucleobase-containing small molecule metabolism | map00350 | Tyrosine metabolism | |
| GO:0098869 | cellular oxidant detoxification | map00643 | Styrene degradation | |
| I9 | GO:0006470 | protein dephosphorylation | map00860 | Porphyrin and chlorophyll metabolism |
| GO:0009072 | aromatic amino acid family metabolic process | map00630 | Glyoxylate and dicarboxylate metabolism | |
| GO:0016311 | dephosphorylation | map00998 | Biosynthesis of secondary metabolites-unclassified | |
| GO:0005975 | carbohydrate metabolic process | map00040 | Pentose and glucuronate interconversions | |
| GO:0009073 | aromatic amino acid family biosynthetic process | map00680 | Methane metabolism | |
| GO:0016053 | organic acid biosynthetic process | map00380 | Tryptophan metabolism | |
| GO:0046394 | carboxylic acid biosynthetic process | map00523 | Polyketide sugar unit biosynthesis | |
| GO:0044281 | small molecule metabolic process | map00340 | Histidine metabolism | |
| GO:0017144 | drug metabolic process | map00261 | Monobactam biosynthesis | |
| GO:0006520 | cellular amino acid metabolic process | map00983 | Drug metabolism-other enzymes | |
Figure 6Leaf+1 metabolite profiles are different between fields 1 (F1) and 2 (F2). Discriminant models between field comparisons generated from the normalized and log10 transformed metabolomics data from the leaf +1 (L1) tissues, combining sampling points (C1, C2, C3, and C4) and experimental fields (F1 and F2). (A) PCA and (B) PLS-DA models for L1 (component 1 Q2 = 0.64317, R2 = 0.70436 and component 2 Q2 = 0.89506, R2 = 0.92523); (C) heatmap representation of the 32 main metabolites responsible for the separations (VIP scores ≥1.0 from PLS-DA analysis) and NA refers to non-detected metabolites.
Figure 7Mature internode metabolite profiles are different between filed 1 (F1) and 2 (F2). Discriminant models for between field comparisons generated from the normalized and log10 transformed metabolomics data from the mature internode (I9) tissues, combining sampling points (C1, C2, C3 and C4) and experimental fields (F1 and F2). (A) PCA and (B) PLS-DA models for I9 (component 1 Q2 = 0.79453, R2 = 0.84836 and component 2 Q2 = 0.92788, R2 = 0.95558); (C) heatmap representation of the 22 main metabolites responsible for the separations (VIP scores ≥ 1.0 from PLS-DA analysis) and NA refers to non-detected metabolites.
Figure 8Pathway activities from the phenylalanine, tyrosine and tryptophan biosynthesis, flavonoid biosynthesis and phenylpropanoid biosynthesis. Pathway activities based on the pathway activity profiling (PAPi) tool of (A) leaves (L1) from F1 and F2; and of (B) mature internodes (I9) from F1 and F2. C1, C2, C3, and C4 refer to sampling points 1, 2, 3 and 4 specifically 4, 8, 11 and 13 months after planting. Bars with different letters (i.e., ‘a’ and ‘b’) indicate statistically significant differences between their activity scores based on ANOVA and Fisher’s LSD (p < 0.05) and bars with the same letters (i.e., ‘a’ and ‘a’) do not have activity scores statistically different.
Figure 9Two plantings of SP80-3280 were carried out in two seasons of the year with different climatic conditions that resulted in the “one-and-a-half-year sugarcane” (Field 1) and “one-year sugarcane” (Field 2) with differences in the plant width, height, brix content and ripening time. A systems biology approach was taken to study sugarcane development including physiological, morphological, agrotechnological, transcriptomics, and metabolomics analyses in plants with 4 (C1), 8 (C2), 11 (C3), and 13 (C4)-months after planting (P) in the leaf +1, immature, intermediate and mature internodes. The number of differentially expressed genes (DEGs) decreased during plant development (from C1 to C4) and the number of metabolites identified decreased from L1 to I9. Most of the variation found within the transcriptomics and metabolomics profiles is attributed to the differences among the distinct anatomical tissues and a summary of the functional categories identified in the tissue profiling is shown here. The integration of both omics highlighted three main metabolic categories as the principal sources of variation in all tissues. The leaves and mature internodes from the two fields presented different intensities of metabolites and natural antisense transcripts with some of them only detected in the leaves of “one-year” sugarcane.